O. Reynard

发表

Human transmission of Ebola virus.

Philip Lawrence, V. Volchkov, V. Volchkova, 2017, Current opinion in virology.

Molecular rationale for hantavirus neutralization by a reservoir host-derived monoclonal antibody

V. Volchkov, G. Paesen, I. Rissanen, 2020, bioRxiv.

Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein

V. Volchkov, G. Paesen, I. Rissanen, 2020, eLife.

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication

V. Volchkov, A. Cimarelli, N. Alazard-Dany, 2015, Viruses.

Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release.

W. Weissenhorn, V. Volchkov, K. Nemirov, 2011, The Journal of infectious diseases.

High Pathogenicity of Nipah Virus from Pteropus lylei Fruit Bats, Cambodia

V. Volchkov, M. Georges-Courbot, Catherine Legras-Lachuer, 2020, Emerging infectious diseases.

Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction

V. Volchkov, N. Thielens, C. Peyrefitte, 2018, Viruses.

Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein

V. Volchkov, N. Thielens, J. Kleman, 2016, Journal of Virology.

Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.

V. Volchkov, C. Basler, O. Martinez, 2011, The Journal of infectious diseases.

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs

V. Volchkov, P. Roingeard, Louis-Marie Bloyet, 2017, PLoS pathogens.

VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.

V. Volchkov, V. Volchkova, K. Nemirov, 2011, The Journal of infectious diseases.

Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection

C. Alabi, M. Porotto, Yun Zhu, 2022, Nature Communications.

Measles Virus-Induced Host Immunity and Mechanisms of Viral Evasion

D. Gerlier, O. Reynard, B. Horvat, 2022, Viruses.

In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity.

G. Trinchieri, M. Colombo, C. Caux, 2004, Novartis Foundation symposium.

Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding

V. Volchkov, E. Decroly, O. Reynard, 2018, Antiviral research.

Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral toleranceInteractions between Henipaviruses and their natural host, fruit bats.

O. Reynard, C. González, B. Horvat, 2022, Current opinion in virology.

The Human Metapneumovirus Matrix Protein Stimulates the Inflammatory Immune Response In Vitro

V. Volchkov, G. Vernet, C. Peyrefitte, 2011, PloS one.

VP40 Octamers Are Essential for Ebola Virus Replication

W. Weissenhorn, V. Volchkov, S. Becker, 2005, Journal of Virology.

RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.

V. Volchkov, V. Volchkova, O. Dolnik, 2015, The Journal of infectious diseases.

Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

V. Volchkov, V. Volchkova, O. Dolnik, 2011, The Journal of infectious diseases.

Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP.

V. Volchkov, O. Reynard, 2015, The Journal of infectious diseases.

Entry of Ebola Virus is an Asynchronous Process.

V. Volchkov, O. Reynard, 2015, The Journal of infectious diseases.

Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.

V. Volchkov, V. Volchkova, M. Mateo, 2011, The Journal of infectious diseases.

Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs

V. Volchkov, V. Volchkova, C. Basler, 2010, Journal of Virology.

Role of Ebola Virus VP30 in Transcription Reinitiation

V. Volchkov, V. Volchkova, S. Becker, 2008, Journal of Virology.

Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

V. Volchkov, V. Volchkova, O. Dolnik, 2006, The Journal of general virology.

Unconventional secretion of Ebola virus matrix protein VP40.

V. Volchkov, C. Basler, S. Reid, 2011, The Journal of infectious diseases.

Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs

H. Perreault, V. Volchkov, S. Conchon, 2016, PloS one.

Ebolavirus Glycoprotein GP Masks both Its Own Epitopes and the Presence of Cellular Surface Proteins

V. Volchkov, V. Volchkova, M. Mateo, 2009, Journal of Virology.

Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

G. Trinchieri, M. Colombo, C. Caux, 2002, The Journal of experimental medicine.

Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus.

V. Volchkov, V. Volchkova, A. Cimarelli, 2018, The Journal of infectious diseases.

[A first outbreak of Ebola virus in West Africa].

V. Volchkov, C. Peyrefitte, O. Reynard, 2014, Medecine sciences : M/S.

Role of VP30 phosphorylation in the Ebola virus replication cycle.

V. Volchkov, V. Volchkova, H. Raoul, 2011, The Journal of infectious diseases.

Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.

V. Volchkov, M. Mateo, A. Khromykh, 2011, The Journal of infectious diseases.

[Crimean-Congo hemorrhagic fever, a future health problem in France?]

V. Volchkov, O. Reynard, Baptiste Martin, 2021, Medecine sciences : M/S.

[Ebola, the first vaccines available].

V. Volchkov, O. Reynard, Baptiste Martin, 2020, Medecine sciences : M/S.